Iron metabolism in critically ill patients developing anemia of inflammation: a case control study - 08/01/26
, Jan M. Binnekade 1 , Benjamin Nota 3 , Kirsten van de Groep 4, 5 , Olaf L. Cremer 4 , Pieter R. Tuinman 6 , Janneke Horn 1 , Marcus J. Schultz 1 , Robin van Bruggen 2 , Nicole P. Juffermans 1 Molecular Diagnosis and Risk Stratification of Sepsis (MARS) Consortium
Friso M. de Beer, Lieuwe D.J. Bos, Gerie J. Glas, Roosmarijn T.M. van Hooijdonk, Laura R.A. Schouten, Marleen Straat, Esther Witteveen, Luuk Wieske, Arie J. Hoogendijk, Mischa A. Huson, Brendon P. Scicluna, Tom van der Poll, Lonneke A. van Vught, Maryse A. Wiewel, Marc J.M. Bonten, Jos F. Frencken, Peter M.C. Klein Klouwenberg, Maria E. Koster-Brouwer, David S.Y. Ong, Diana M. Verboom
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Anemia occurring as a result of inflammatory processes (anemia of inflammation, AI) has a high prevalence in critically ill patients. Knowledge on changes in iron metabolism during the course of AI is limited, hampering the development of strategies to counteract AI. This case control study aimed to investigate iron metabolism during the development of AI in critically ill patients.
Methods |
Iron metabolism in 30 patients who developed AI during ICU stay was compared with 30 septic patients with a high Hb and 30 non-septic patients with a high Hb. Patients were matched on age and sex. Longitudinally collected plasma samples were analyzed for levels of parameters of iron metabolism. A linear mixed model was used to assess the predictive values of the parameters.
Results |
In patients with AI, levels of iron, transferrin and transferrin saturation showed an early decrease compared to controls with a high Hb, already prior to the development of anemia. Ferritin, hepcidin and IL-6 levels were increased in AI compared to controls. During AI development, erythroferrone decreased. Differences in iron metabolism between groups were not influenced by APACHE IV score.
Conclusions |
The results show that in critically ill patients with AI, iron metabolism is already altered prior to the development of anemia. Levels of iron regulators in AI differ from septic controls with a high Hb, irrespective of disease severity. AI is characterized by high levels of hepcidin, ferritin and IL-6 and low levels of iron, transferrin and erythroferrone.
Le texte complet de cet article est disponible en PDF.Keywords : Critical care, Anemia, Iron, Inflammation, Sepsis, Hepcidin
Plan
| Robin van Bruggen and Nicole P. Juffermans contributed equally to this work |
Vol 8 - N° 1
Article 56- 2018 Retour au numéro
Article précédent
- Point-of-care ultrasonography in Brazilian intensive care units: a national survey
- José Augusto Santos Pellegrini, Ricardo Luiz Cordioli, Ana Cristina Burigo Grumann, Patrícia Klarmann Ziegelmann, Leandro Utino Taniguchi
- Association of intensive care unit delirium with sleep disturbance and functional disability after critical illness: an observational cohort study
- Marcus T. Altman, Melissa P. Knauert, Terrence E. Murphy, Amy M. Ahasic, Zeeshan Chauhan, Margaret A. Pisani
Bienvenue sur EM-consulte, la référence des professionnels de santé.